|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/437 | |
| A61K 31/519 | |||
| A61K 31/404 | |||
| A61K 31/44 | |||
| A61K 31/47 | |||
| A61K 31/496 | |||
| A61K 31/5025 | |||
| A61K 31/506 | |||
| A61K 31/53 | |||
| A61K 31/5377 | |||
| A61P 35/00 |
| (11) | Number of the document | 3023101 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14826874.1 |
| Date of filing the European patent application | 2014-07-17 | |
| (97) | Date of publication of the European application | 2016-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2014/069105 |
| Date | 2014-07-17 |
| (87) | Number | WO 2015/008844 |
| Date | 2015-01-22 |
| (30) | Number | Date | Country code |
| 2013149958 | 2013-07-18 | JP |
| (72) |
SOOTOME, Hiroshi, JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd.,
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444,
JP
|
| (54) | THERAPEUTIC AGENT FOR FGFR INHIBITOR-RESISTANT CANCER |
| THERAPEUTIC AGENT FOR FGFR INHIBITOR-RESISTANT CANCER |